00:00
				
				Evotec, Dr. Cord Dohrmann, Evotec - Partner of choice for oncology drug discovery.
	 
	
		00:08
				
				, Evotec at a glance
	 
	
		00:15
				
				R&D;, Profitable, revenue,  growth, alliances, pipeline, Phase III, Phase II and Phase I , Leader in high quality drug discovery solutions
	 
	
		01:18
				
				scientists, location, Global reach for global projects -  approx. 600 scientists
	 
	
		02:38
				
				alliances, biology, Metabolics, Oncology, CNS, Immunology , Drug discovery alliances & more
	 
	
		03:08
				
				value chain, cell types, chemistry, Best-in-class platforms yield superior productivity
	 
	
		04:03
				
				pipeline, risk, Indication, Commercials
, Deep clinical pipeline without financial risk
	 
	
		04:46
				
				, Experience and current oncology partners
	 
	
		04:50
				
				oncology platform, Targets, Tumor metabolism, 
compounds, Productive oncology platform
	 
	
		05:36
				
				oncology alliances, Drug discovery partners, 
Biomarker development
, Current oncology alliances
	 
	
		07:20
				
				, Examples of cancer alliances
	 
	
		07:25
				
				Boehringer Ingelheim-Alliance, oncology, Milestones , Boehringer Ingelheim-Alliance Focus on cancer
	 
	
		08:10
				
				Biomarkers , Response Prediction,  Personalized Medicine, 
chemotherapy, Targeted Therapies
,  The future paradigm in oncology
	 
	
		08:50
				
				Phospho-signatures as biomarkers, 
proteins,  pathways,  phosphorylation , Phospho-signatures as biomarkers
	 
	
		09:40
				
				oncology, biomarker development, PhosphoScout,  quantification of cellular phosphorylation 
, Roche oncology alliance
	 
	
		10:06
				
				, Opportunities with Evotec
	 
	
		10:10
				
				Opportunities, Drug Design platforms, Mesoscale, acetylomics, Phenotypic,  Epigenetic , Leveraging Evotec expertise in oncology
	 
	
		10:38
				
				, Evotec - contact info